Ads

 

Ads

 

Ads

 

World Top 500 Companies by Net Income as of 2023

  1. Rank by Revenue in Search Criteria: 7521Annual Revenue in USD: 31 Million USDAnnual Operating Income in USD: Annual Net Income in USD: -154 Million USDAnnual Results for Period Ending: Dec-2021 ending yearWorld Rank (Jul-30-2023): 4,317Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: Employee Count as of Date:
    Company Profile:

    Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Headquarters is in UK.

  2. Rank by Revenue in Search Criteria: 7522Annual Revenue in USD: 47 Million USDAnnual Operating Income in USD: -154 Million USDAnnual Net Income in USD: -154 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 7,820Market Cap (Jul-30-2023): 1 Billion USDEmployee Count: 80Employee Count as of Date: As on 2020
    Company Profile:
    Kymera is a Biopharmaceutical company. It is a developing novel protein degrader therapeutics to treat disease in powerful new ways which harness the body's natural protein degradation system to selectively degrade disease causing proteins with the goal of completely removing them from the body. The company annual revenue is 10.4 million USD and 67 employees as on 2019. The headquarters is in USA.
  3. Rank by Revenue in Search Criteria: 7523Annual Revenue in USD: 1,819 Million USDAnnual Operating Income in USD: Annual Net Income in USD: -156 Million USDAnnual Results for Period Ending: Dec-2020 ending yearWorld Rank (Jul-30-2023): 1,800Market Cap (Jul-30-2023): Employee Count: 2,841Employee Count as of Date: As on February 2021
    Company Profile:

    Grubhub is online food and beverages delivery company with headquarters is in USA.

    Just Eat Takeaway acquired Grubhub for 7.3 Billion USD in 2020 and completed acquisition process in 2021.

     

  4. Rank by Revenue in Search Criteria: 7524Annual Revenue in USD: 0 Million USDAnnual Operating Income in USD: Annual Net Income in USD: -156 Million USDAnnual Results for Period Ending: Mar-2022 ending yearWorld Rank (Jul-30-2023): 4,418Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: 70Employee Count as of Date: As on 2021
    Company Profile:
    Immunovant is a Clinical Stage Biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The headquarters is in USA.
  5. Rank by Revenue in Search Criteria: 7525Annual Revenue in USD: -146 Million USDAnnual Operating Income in USD: Annual Net Income in USD: -157 Million USDAnnual Results for Period Ending: Dec-2020 ending yearWorld Rank (Jul-30-2023): 6,585Market Cap (Jul-30-2023): Employee Count: Employee Count as of Date:
    Company Profile:
    Secure Income REIT is a specialising in generating long term, inflation protected income from real estate investments company owns a portfolio of 160 key operating real estate assets with a weighted average unexpired lease term of 19.7 years as at 30 June 2021. The company annual revenue is 106.9 million GBP and total assets are 2,218 million GBP as on 2020. The headquarters is in UK.
  6. Rank by Revenue in Search Criteria: 7526Annual Revenue in USD: 2 Million USDAnnual Operating Income in USD: -165 Million USDAnnual Net Income in USD: -157 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 7,713Market Cap (Jul-30-2023): 1 Billion USDEmployee Count: Employee Count as of Date:
    Company Profile:
    Verve Therapeutics is the preeminent company developing gene editing medicines to treat patients with cardiovascular disease. The headquarters is in USA.
  7. Rank by Revenue in Search Criteria: 7527Annual Revenue in USD: 10,386 Million USDAnnual Operating Income in USD: 1,551 Million USDAnnual Net Income in USD: -157 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 821Market Cap (Jul-30-2023): 23 Billion USDEmployee Count: 30,834Employee Count as of Date: As on 2022
    Company Profile:

    Carlsberg Group is brewing company with headquarters is in Denmark. They are into both alcoholic beverages and non-alcoholic beverages. They manufacture beers, soft drinks.

    More than 40,000 people work for Carlsberg Group and their products are sold in more than 150 markets.

  8. Rank by Revenue in Search Criteria: 7528Annual Revenue in USD: 38 Million USDAnnual Operating Income in USD: Annual Net Income in USD: -157 Million USDAnnual Results for Period Ending: Dec-2021 ending yearWorld Rank (Jul-30-2023): 7,387Market Cap (Jul-30-2023): 1 Billion USDEmployee Count: Employee Count as of Date:
    Company Profile:
  9. Rank by Revenue in Search Criteria: 7529Annual Revenue in USD: 16,043 Million USDAnnual Operating Income in USD: -742 Million USDAnnual Net Income in USD: -158 Million USDAnnual Results for Period Ending: Mar-2023 ending yearWorld Rank (Jul-30-2023): 788Market Cap (Jul-30-2023): 24 Billion USDEmployee Count: 10,754Employee Count as of Date: As on 2022
    Company Profile:

    SSE PLC is a Electricity generation and distribution company. SSE Energy Services was acquired by OVO Energy from SSE plc. SSE Energy Services is now owned and operated by OVO Energy. SSE's vision is to be a leading energy company in a low carbon world. Headquarters is in UK.

    SSE PLC Business Segments:

    • SSE Renewables
    • SSEN Distribution
    • SSEN Transmission
    • SSE Thermal
    • SSE Energy Solutions
    • SSE Airtricity
  10. Rank by Revenue in Search Criteria: 7530Annual Revenue in USD: 1,111 Million USDAnnual Operating Income in USD: -142 Million USDAnnual Net Income in USD: -158 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 3,088Market Cap (Jul-30-2023): 5 Billion USDEmployee Count: 2,280Employee Count as of Date: As on 2023
    Company Profile:

    Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. Headquarters is in Dublin, Ireland.

    Alkermes seeks to develop innovative medicines that help address the unmet needs and challenges of people living with debilitating diseases.

    The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer.

Share

Ads